Recent Headlines
AnaSpec to Host Bone Marrow Donor Drive
AnaSpec, Inc. has partnered with AADP to host a bone marrow donor drive on the AnaSpec campus on February 1, 2010. The goal of the event is to raise awareness around bone marrow donations and add new donors to the bone marrow donor registry. The event will take place in AnaSpec’s cafeteria... - January 20, 2010 - AnaSpec, EGT Group
Adaptive Clinical Research is Expanding Opportunities in Personalized Medicine: CED Invites Health Decisions to Discuss
Health Decisions CEO Dr. Michael Rosenberg will forecast the future of molecular testing at the CED 2010 Biotech Conference - January 09, 2010 - Health Decisions
Two Long-Established Independent IRBs Discussing Merger
Two Independent Review Boards, responsible for the review of human subject research are discussing a merger to utilize their combined 46 years of experience to create a new Limited Liability Corporation. - January 07, 2010 - Ethical and Independent Review Services
AnaSpec Introduces Its Longest-Wavelength Dye, HiLyte Fluor™ 750
Highlighting its collection of high performance HiLyte Fluor™ dyes, AnaSpec has introduced HiLyte Fluor™ 750. Spectrally similar to Cy7™ dye, HiLyte Fluor™ 750 dye is the longest-wavelength HiLyte Fluor™ dye currently available. Its fluorescence emission maximum at... - January 02, 2010 - AnaSpec, EGT Group
AnaSpec Adds Z-Fish™ MMP Antibodies to MMP Research Portfolio
AnaSpec has introduced the industry’s most comprehensive collection of anti-MMP zebrafish (Z-Fish™) specific antibodies. - December 23, 2009 - AnaSpec, EGT Group
Wiley Press to Release 'The Agile Approach to Adaptive Research: Optimizing Efficiency in Clinical Development'
Michael Rosenberg, MD, MPH, provides a comprehensive guide to the adaptive methods that are shaping the future of clinical trials - December 19, 2009 - Health Decisions
Genescient Receives Additional Angel Funding
Genescient Corporation receives an additional $500,000 in angel funding. - December 17, 2009 - Genescient Corporation
NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont®
The National Eye Institute (NEI) awarded a $2.18 million grant to Aciont Inc. to help fund its development of a non-invasive, passive diffusion-based treatment for severe, non-infectious uveitis. - December 12, 2009 - Aciont Inc.
RayBiotech Introduces Multiplex ELISA Detecting 200 Human Proteins
RayBiotech, the Protein Array Pioneer Company, has just introduced the Quantibody® Human Cytokine Array 4000 (or Human Q4000, catalog number QAH-CAA-4000), which can quantitatively detect expression of 200 different proteins in a single experiment. The kit consists of 5 different quantitative... - December 12, 2009 - RayBiotech, Inc
AnaSpec Introduces α & β -Synuclein Recombinant Proteins
AnaSpec has announced the release of two new recombinant proteins, a-synuclein (SNCA) and b-Synuclein (SNCB). These proteins, along with g-synuclein (SNCG), are members of the synuclein family of small proteins expressed primarily in neural tissue and in some tumors.1 Synuclein proteins, found only... - November 26, 2009 - AnaSpec, EGT Group
Gates Foundation Funds Functional Genetics, Inc. to Study TSG101 Antibody Targeting of HIV-Infected Cells
Functional Genetics, Inc. today announced a grant from the Bill & Melinda Gates Foundation to pursue an innovative approach for antibody-based targeting of HIV/AIDS. Under the terms of the agreement, Functional Genetics will investigate the use of TSG101 antibody targeting of HIV-infected cells... - November 23, 2009 - Functional Genetics, Inc.
AnaSpec Introduces SensoLyte 520 Calpain Kit
AnaSpec has announced the release of the SensoLyte 520 Calpain Activity Assay Kit, the industry’s first longest wavelength FRET based calpain assay. Optimized for detecting calpain activity, this kit contains a novel internally quenched 5-FAM/QXLTM 520 FRET substrate. Cleavage of this FRET... - November 20, 2009 - AnaSpec, EGT Group
KLIXAR Joins Health Decisions’ Global Network of CROs Advocating Higher Efficiency Standards
Latin American CRO is now a certified partner in Health Decisions’ Agile Clinical Network, dedicated to improving processes and systems across global trials - November 20, 2009 - Health Decisions
Selvita to Present a Poster on the Developments of Its Oncology Program During the 2009 AACR-NCI-EORTC International Conference
Selvita Ltd. announced that it will present a poster on the company's investigational compounds during the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, which will be held on November 15-19, 2009 in Boston, MA, USA. Selvita will present the poster # A242,... - November 18, 2009 - Selvita
CuraBase to be Presented at the AACR-NCI-EORTC Molecular Targets and Cancer Therpeutics Conference in Boston
Targeted Therapeutics Consulting, Inc. announced today that its lead product, the cancer drug development database CuraBase®, will be introduced to the scientific community at the AACR-NCI-EORTC Molecular Targets and Cancer Therpeutics Conference in Boston on Monday, November 16. Dr. W. Michael... - November 14, 2009 - Targeted Therapeutics Consulting, Inc.
ALT BioPharma to Auction Lab Equipment Online on Monday, November 16, 2009
Opening Bids Start as Low as $5 on Hundreds of New and Used Centrifuges, Water Baths, HPLC Components, Incubators, Consumables, and More From Agilent, Perkin Elmer, Beckman and Others. - November 14, 2009 - American Laboratory Trading Inc.
Functional Genetics Announces Discovery of Target That Regulates Alzheimer's Disease
Investigators at Functional Genetics, working with scientists at the Burnham Institute for Medical Research, Stanford University and Rockefeller University, have utilized its proprietary RHGP discovery technology to identify a novel gene (Rps23r1) in mice that reduces the accumulation of two toxic... - November 14, 2009 - Functional Genetics, Inc.
AnaSpec Introduces Agr D1 & D2 Thiolactone GO™ Peptides
AnaSpec has announced the release of two structurally complex peptides, Agr D1 Thiolactone and Agr D2 Thiolactone, as part of its GO™ (catalog) peptides offering. In Gram-positive bacteria, such as in Staphylococcus aureus, physiological changes in the bacterial population are dependent on... - November 14, 2009 - AnaSpec, EGT Group
AnaSpec Improves Sensitivity of SensoLyte® pNPP Alkaline Phosphatase Assays
AnaSpec’s SensoLyte® pNPP Alkaline Phosphatase Assay kits now contain a specially formulated pNPP substrate. This new substrate offers the following advantages: Ready to use – no need to reconstitute pNPP powder Improved sensitivity – detects as low as 0.02 ng alkaline... - November 11, 2009 - AnaSpec, EGT Group
Heath Decisions CIO Maurice Hagar Wins Business Leader Media's Movers & Shakers Award
Business Leader Media’s sixth annual award honors up-and-coming business leaders in the Triangle community. - November 08, 2009 - Health Decisions
Eurogentec Announces Agreement to Acquire AnaSpec, Inc.
Eurogentec S.A. announces today a final agreement for the acquisition of AnaSpec Inc, a privately held proteomics company based in Fremont, California. - October 25, 2009 - AnaSpec, EGT Group
AnaSpec Introduces New Cys-Containing b-Amyloid Peptides
AnaSpec has added the following amyloid peptides to its selection: b-amyloid (1-40) S26C; b-amyloid (1-42) S26C dimer; b-amyloid (1-42) S26C and other Cys-containing b-amyloid peptides - October 21, 2009 - AnaSpec, EGT Group
Health Decisions Builds a Network of International CROs Trained in High-Efficiency Adaptive Research
Adaptive CRO invites like-minded research organizations from around the world to get certified in Agile Clinical Development - October 18, 2009 - Health Decisions
AnaSpec Introduces Beta- Secretase Enzyme & Assay
As one of the world’s largest providers of beta-amyloid peptides and Alzheimer’s related research products, AnaSpec has announced its latest offering – the human recombinant beta-secretase enzyme. b- secretase (BACE1) is a key protease involved in the production of beta-amyloid... - October 18, 2009 - AnaSpec, EGT Group
Sustainable Now Technologies, Inc. Files Energy Conversion Machine Patent
Sustainable Now Technologies today announced the filing of their first patent describing their Energy Conversion Machine (ECM) technologies. - October 16, 2009 - Sustainable Now Technologies
AnaSpec Introduces Expanded Selection of Anti-Tau Antibodies
AnaSpec has announced the release of 4 additional new phosphospecific anti-Tau antibodies. - October 15, 2009 - AnaSpec, EGT Group
Solving the Challenges of Adaptive Clinical Trials: Web Seminar Will Reveal Universal, Risk-Resistant Methods for Improving Study Efficiency
Health Decisions and the Center for Business Intelligence present the webinar "Solving the Challenges of Clinical Trials," which will be held Wednesday, October 28 from 11:00 am to noon EDT. Health Decisions is also holding a weekly drawing for free registration passes (a value of $295). To enter, visit http://www.HealthDec.com/page/webinar. - October 09, 2009 - Health Decisions
AnaSpec Introduces Rat-Specific SensoLyte® 520 Renin Assay Kit
AnaSpec is pleased to announce the release of a rat renin specific assay – the SensoLyte® 520 Rat Renin Assay Kit. - October 07, 2009 - AnaSpec, EGT Group
AnaSpec Introduces Z-Fish™ Anti-p53 Antibodies
AnaSpec has announced the release of a zebrafish specific p53 antibody, the Z-Fish™ Anti-p53. - October 04, 2009 - AnaSpec, EGT Group
ANAVEX Contracts FORENAP Pharma for Clinical Trials of ANAVEX 2-73 in Alzheimer’s Disease
Anavex Life Sciences Corp. has selected FORENAP Pharma EURL as the contract research organization (CRO). - October 02, 2009 - Anavex Life Sciences Corp.
AnaSpec Introduces New HiLyte Fluor™ 405 Fluorescent Probe
AnaSpec has introduced the newest member of the HiLyte FluorTM family - HiLyte Fluor™ 405 (Ex/Em=404/428 nm), a bright blue fluorescent probe. HiLyte FluorTM dyes are a series of superior fluorescent labeling dyes that span the full visible spectrum. They are optimized for maximum brightness... - October 01, 2009 - AnaSpec, EGT Group
AnaSpec’s Published References Pass 800
As compiled by Stanford University’s Highwire Press, the number of published papers that cite AnaSpec’s products has passed 800. Products cited include AnaSpec’s custom and catalog peptides, antibodies, assay kits, dyes, standard amino acids, unusual amino acids and synthesis... - September 30, 2009 - AnaSpec, EGT Group
New HD360˚ Module Gives Clinical Trial Monitors Greater Control While Reducing Costs
Health Decisions integrates Monitor View into its HD360˚ clinical trial management system. - September 27, 2009 - Health Decisions
RayBiotech to Award Biomarker Discovery Grants
RayBiotech, Inc., today announced today the establishment of its Biomarker Discovery Pilot Grant program, consisting of restricted grants of $10,000 to $20,000 worth of RayBiotech products and services to conduct their proposed biomarker research, which would potentially be sufficient to generate preliminary data for additional grant funding. - September 26, 2009 - RayBiotech, Inc
MedSource Hires New Associate Director of Clinical Operations
MedSource, a Contract Research Organization (CRO) providing Phase I-IV clinical trials support, announced today that Ms. Parisa Jabbarzadegan has joined its company as Associate Director of Clinical Operations. With more than 12 years of experience in the clinical research industry she brings a... - September 25, 2009 - MedSource
Anavex Completes Scale-Up Manufacturing of ANAVEX 2-73 for Phase I Alzheimer’s Disease Clinical Trials
Anavex Life Sciences Corp. today announced the completion of scale-up manufacturing of ANAVEX 2-73, its lead compound for the treatment of Alzheimer’s disease. - September 23, 2009 - Anavex Life Sciences Corp.
MedSource, a Contract Research Organization (CRO) Specializing in Complex Clinical Trials, Ranked No. 11 on List of Fastest Growing Companies in Houston
Companies making the Houston Business Journal’s list were ranked by percentage of revenue growth over the past two years. - September 23, 2009 - MedSource
AnaSpec Introduces Custom Services & Reagents for Hydrocarbon-Stapled Peptides
AnaSpec now offers custom synthesis of hydrocarbon-stapled peptides. - September 20, 2009 - AnaSpec, EGT Group
BIOCOM Biotech and AnaSpec Sign Distributor Agreement
AnaSpec and BIOCOM Biotech today announced a non-exclusive distributor agreement that will allow BIOCOM Biotech to distribute AnaSpec’s catalog and custom products throughout South Africa. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted, “AnaSpec is pleased... - September 19, 2009 - AnaSpec, EGT Group
MedSource Named to Inc. 500/5000 List of Fastest-Growing Companies in America for the Second Time
Houston-based company ranks No. 1232 on the 2009 Inc. 5000 with three-year sales growth of 258 percent - September 08, 2009 - MedSource
AnaSpec Introduces Calcein AM for Live Cell Staining
Calcein AM (Calcein acetoxymethyl ester), a non-fluorescent, cell permeable compound, converts to the strongly green fluorescent calcein when hydrolyzed by intracellular esterases in live cells.1-2 It is widely used for determining cell viability since the fluorescence intensity of calcein is... - August 27, 2009 - AnaSpec, EGT Group
AnaSpec Introduces New Click Chemistry Reagents
Click chemistry is a newer approach to the synthesis of drug-like molecules that can accelerate the drug discovery process. Sharpless, et al. defined what makes a click reaction as one that is wide in scope and easy to perform, uses only readily available reagents, and is insensitive to oxygen and... - August 23, 2009 - AnaSpec, EGT Group
Caffeine Cuts Male Mating Success
New study suggests that, when long-term effects are considered, two commonly ingested stimulants are not created equal. - August 19, 2009 - Genescient Corporation
Health Decisions Contributes Adaptive Research Best Practices to Wiley’s "Clinical Trials Handbook"
CEO Michael Rosenberg authors an in-depth review of progressive research in new interdisciplinary manual - August 15, 2009 - Health Decisions
MedSource Hires New Vice President of Clinical Operations
MedSource specializes in complex diseases and study designs and has experience in more than 400 trials in Phases I-IV. - August 14, 2009 - MedSource
AnaSpec Introduces New Z-Fish™ Antibodies for Cell Cycle Control Research
AnaSpec is pleased to announce the release of a series of zebrafish specific Z-Fish™ antibodies for use in cell cycle control research. - August 13, 2009 - AnaSpec, EGT Group
AnaSpec Introduces New SensoLyte® 520 Thiol Quantitation Kit
AnaSpec has announced the release of the SensoLyte® 520 Thiol Quantitation Kit (patent pending), an ultra-sensitive, robust and easy-to-use fluorescent assay for measurement of total thiol level. - August 09, 2009 - AnaSpec, EGT Group
AnaSpec Introduces Industry’s First Suite of MOG Reagents & Assay Kits
AnaSpec is pleased to be the first in the industry to provide a whole suite of reagents and assay kits for the advancement of MS research. This includes MOG proteins, peptides, antibodies and assay kits. - July 26, 2009 - AnaSpec, EGT Group
Cellexus Launches 50 Litre Single-Use, Disposable Bioreactor System
This introduction of the 50 litre format follows the successful launch of the CellMaker Regular 8 litre system in October 2008. - July 26, 2009 - Cellexus Ltd
AnaSpec Introduces New SensoLyte® β-Galactosidase Assay Kits
AnaSpec is pleased to announce the release of 3 new assay kits for measuring β-galactosidase activity - July 23, 2009 - AnaSpec, EGT Group